Research advancement of bone marrow and adipose-derived mesenchymal stem cells in the treatment of eye diseases
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

National Natural Science Foundation of China(No.81660158); Natural Science Key Project of Jiangxi Province(No.20161ACB21017); Youth Science Foundation of Jiangxi Province(No.20151BAB215016); Key Research Foundation of Jiangxi Province(No.20151BBG70223, 20181BBG70004); Excellent Talents Development Project of jiangxi Province(No.S2019RCQNB0259)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Mesenchymal stem cells(MSCs)are multipotent cells with high proliferation ability that can differentiate into a variety of cell types. Thus great plasticity was provided for the regeneration of somatic cells in animal individual growth. Recently, MSCs have been applied to the treatment of traumatic and degenerative diseases on account of its distinct biologic peculiarity. The cells have tremendous potential in the clinical application. This article reviewed clinical treatment of ophthalmic diseases, administration route, methods of acquiring and security about two of MSCs derived from bone marrow and adipose tissue(BMSCs and ADSCs).

    Reference
    Related
    Cited by
Get Citation

Chen-Yu Yu, Rong-Bin Liang, Yi Shao. Research advancement of bone marrow and adipose-derived mesenchymal stem cells in the treatment of eye diseases. Guoji Yanke Zazhi( Int Eye Sci) 2021;21(1):62-65

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:February 10,2020
  • Revised:December 08,2020
  • Adopted:
  • Online: December 22,2020
  • Published: